-+ 0.00%
-+ 0.00%
-+ 0.00%

Is British American Tobacco (LSE:BATS) Cheap After Weaker Guidance And Falling Cigarette Volumes?

Simply Wall St·08/15/2026 04:32:51
Listen to the news

Why British American Tobacco Stock Is Back in Focus

British American Tobacco (LSE:BATS) is back on many watchlists after shares fell following guidance for weaker full year sales and profit, driven by faster declines in global cigarette volumes.

See our latest analysis for British American Tobacco.

Over the past few months British American Tobacco’s share price has come under pressure, with a 90 day share price return that is down 13.36% and a 7 day share price return that is down 4.68%, even though the 1 year total shareholder return is 6.31% and the 5 year total shareholder return is up more than 2x. This suggests recent momentum is fading despite a longer record of value creation.

If you are weighing British American Tobacco against other opportunities, this could be a good moment to scan stocks that may benefit from different growth drivers using our screener for 8 top founder-led companies

British American Tobacco still looks like a powerful cash generator on paper, yet the share price has pulled back after weaker guidance. So are you looking at a quality business temporarily on sale, or one that is fairly priced for its risks?

Most Popular Narrative: 16.2% Undervalued

British American Tobacco’s most followed valuation narrative sets a fair value of £50.27 per share versus the last close at £42.14, which implies a meaningful gap that this framework attempts to explain using earnings, margins and a specific discount rate of 8.68%.

Strong uptake and premiumization of reduced-risk new category products (Modern Oral, Heated, and Vapour), combined with successful innovation rollouts (Velo Plus, glo Hilo, Vuse Ultra), are driving higher contribution margins and gross margins, setting the stage for structural net margin and earnings expansion as these products scale.

Read the complete narrative.

Want to see what sits behind that upgrade in margins and earnings for British American Tobacco? The narrative leans on steady top line progress, slightly leaner profitability, and a richer earnings multiple a few years out. Curious which forecast mix of revenue growth, margins and valuation multiples has to hold for that fair value to stack up.

Result: Fair Value of £50.27 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, British American Tobacco’s story can still be knocked off course if cigarette volume declines accelerate or if tighter regulation curbs vapour and pouch growth.

Find out about the key risks to this British American Tobacco narrative.

Next Steps

Given the mix of concern and optimism around British American Tobacco, it makes sense to move quickly and test the numbers for yourself. To weigh those risks against the potential upside, start with the 4 key rewards and 2 important warning signs

Looking for more investment ideas beyond British American Tobacco?

Do not stop with British American Tobacco. Use the Simply Wall Street screener to compare fresh ideas, cross check risks, and pressure test your portfolio decisions.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.